Search Results for FIX

Product: Ceveron® Fixing Screw

Product: Ceveron® TGA RB Kit

Product: CMV Brite Kit

Product: CMV Brite Turbo Kit

Product: DiaPharma Factor IXa Purified Enzyme, Human

Product: Rossix Factor IXa Calibrator

Product: Rossix Factor IXa Control

Product: Rossix FXIa Calibrator

Product: Rossix FXIa Control

Product: Rossix Phospholipid-TGT, 0.50mmol/L

Product: Rox Factor IX

Product: Rox Factor IX-A

Page:

Page: Antithrombin (ATIII)

Page: Assays for your Gene Therapy Research in Rare Diseases

Page: CHROMOGENIC FACTOR X ASSAYS vs the PT/INR TO MONITOR SUBJECTS ON COUMADIN THERAPY WHEN AN INDIVIDUAL APPROACH IS NECESSARY

Page: Clot Club - Here The Clot Thickens

Page: Coagulation

Page: Collagen

Page: Detecting Hemoglobin Variants during Sickle Cell Disease Research: Which Method is Best?

Page: DiaPharma - We Deliver Solutions

Page: Factor IX (FIX)

Page: Factor VIII (FVIII)

Page: Factor XI (FXI)

Page: Hemophilia

Page: Heparin

Page: Hypercoagulation During Sickle Cell Disease

Page: It’s Not Just Support. It’s Solutions.

Page: IVIG

Page: Laboratory Tests for von Willebrand Factor (VWF)

Page: Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?

Page: The Chromogenic Factor X Assay (CFX)

Page: The Debate of Early-Liver Transplantation for Alcohol-associated Liver Diseases

Page: The Latest Research on Direct Oral Anticoagulant (DOAC) Interferences in Testing

Page: Thrombophilia

Page: THSNA 2020 Virtual Meeting

Page: THSNA 2022 Recap

Page: Tools for Sickle Cell Disease Research

Page: UPDATE ON THE DIRECT ORAL ANTICOAGULANTS (DOACs): WHERE ARE WE IN THE LABORATORY ALMOST TEN YEARS LATER?

News: American Society of Clinical Oncology (ASCO) Annual Meeting 2017

News: Assays Available from Diapharma

News: Assays for your Gene Therapy Research in Rare Diseases

News: Chromogenic Factor VIII and FIX Assays For Hemophilia Studies

News: Chromogenic Factor VIII and FIX Assays for Hemophilia Studies

News: Chromogenic FVIII and FIX Assays for Hemophilia Studies

News: Clot Club: Hypercoagulation During Sickle Cell Disease

News: Connect with DiaPharma at ASH 2022 in New Orleans

News: Diapharma expands line of proteins

News: Diapharma Newsletter Spring 2017

News: Interact LIVE with our partner Technoclone during the ISTH 2020 Congress!

News: Learn the Latest from DiaPharma at ISTH 2021

News: Measure What Really Matters in Anti-cancer Drug Development

News: Next Generation Assays for Hemophilia A & B Gene Therapy Research

News: Now Available! M65 EpiRat™ ELISA for drug safety studies

News: PRECISELY BALANCED HEMOSTASIS

News: Quality Products for Anticoagulation Research

News: Sickle Cell Matters

News: Thank you for visiting us at THSNA 2018!

News: Upsetting the Balance in Liver Disease and Coagulation Research

News: Visit DiaPharma at THSNA 2020 Virtual Conference

News: What's New at Diapharma?

News: What's New at Diapharma? Our Team is Expanding!

News: YOUR SOURCE FOR HEMOPHILIA CLINICAL AND RESEARCH SOLUTIONS

Faq: I received another BioTek® error when trying to power export. What should I do?

Faq: What is the difference between Chromogenix Coamatic® FVIII, Coatest® SP FVIII, and Coatest® SP FVIII?

Faq: What is the function of antithrombin and what is its interaction with thrombin and heparin?

Faq: What is the measurement principle behind the FVIII chromogenic kits?